Dunad Therapeutics
PrivateLast Round
Strategic
Nov 2, 2021
Total Funding Raised
$30.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Dunad Therapeutics is a biotechnology company that develops next-generation targeted oral protein degradation therapies for oncology and CNS indications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dunad Therapeutics Comparables
Compare Dunad Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RDP Pharma AG | 87% | |
| General Proximity | 87% | |
| Plexium | 86% |
Dunad Therapeutics Funding Rounds
Historical fundraising activity
Dunad Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Strategic, Seed |
| BioGeneration Ventures | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Job postings surged from 0 to 13 roles, representing 100% of headcount.
- Jul 4, 2025
Monthly visitors increased 52% MoM.
Dunad Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dunad Therapeutics's valuation, stock price, and market status.
Is Dunad Therapeutics a public or private company?
Dunad Therapeutics is a private company.
What is the current stock price of Dunad Therapeutics?
Dunad Therapeutics is a private company, so its shares have no public market price. Caplight tracks Dunad Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dunad Therapeutics worth (valuation)?
Valuation information for Dunad Therapeutics is not publicly available.
Can I buy Dunad Therapeutics stock?
Dunad Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dunad Therapeutics's last funding round?
Dunad Therapeutics's most recent funding round was Strategic on November 2, 2021.
Who are the main investors in Dunad Therapeutics?
Key investors in Dunad Therapeutics include Epidarex Capital.
Will Dunad Therapeutics IPO soon?
No public IPO plans have been announced for Dunad Therapeutics.
How can I track Dunad Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Dunad Therapeutics's shares on secondary markets.